The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $1.77

Today's change+0.01 +0.57%
Updated December 2 3:59 PM -5GMT. Delayed by at least 15 minutes.
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $1.77

Today's change+0.01 +0.57%
Updated December 2 3:59 PM -5GMT. Delayed by at least 15 minutes.

Repros Therapeutics Inc up (U.S.)$0.01

Repros Therapeutics Inc closed up Friday by (U.S.)$0.01 or 0.57% to (U.S.)$1.77. Shares have lost 5.85% over the last five days, but have gained 46.28% over the last year to date. This security has underperformed the S&P 500 by 4.26% during the last year.

Key company metrics

  • Open(U.S.) $1.81
  • Previous close(U.S.) $1.76
  • High(U.S.) $1.81
  • Low(U.S.) $1.76
  • Bid / Ask(U.S.) $1.38 / (U.S.) $2.79
  • YTD % change+46.28%
  • Volume79,565
  • Average volume (10-day)108,704
  • Average volume (1-month)174,484
  • Average volume (3-month)286,716
  • 52-week range(U.S.) $0.80 to (U.S.) $3.48
  • Beta-0.80
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.80
Updated December 2 3:59 PM -5GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4456
Selling / general / administrative2225
Research & development2331
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-4-4-5-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-4-5-6
Income after tax-4-4-5-6
Income tax, total--------
Net income-4-4-5-6
Total adjustments to net income--------
Net income before extra. items-4-4-5-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-4-5-6
Inc. avail. to common incl. extra. items-4-4-5-6
Diluted net income-4-4-5-6
Dilution adjustment--------
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.17-0.18-0.20-0.26
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.17-0.18-0.20-0.26